73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Addition of durvalumab, bevacizumab to TACE beneficial in liver cancer

Addition of durvalumab, bevacizumab to TACE beneficial in liver cancer

by Elana GotkineFor patients with embolization-eligible unresectable hepatocellular carcinoma (uHCC), the addition of durvalumab (D) and bevacizumab (B) to transarterial chemoembolization (TACE) impro

Addition of durvalumab, bevacizumab to TACE beneficial in liver cancer

by Elana GotkineFor patients with embolization-eligible unresectable hepatocellular carcinoma (uHCC), the addition of durvalumab (D) and bevacizumab (B) to transarterial chemoembolization (TACE) impro
Cancer patients benefit from therapy that changes negative thoughts, behavior

Cancer patients benefit from therapy that changes negative thoughts, behavior

Many cancer patients struggle with their conditions by having negative thoughts, behaviors and emotions.However, when they identify and “talk back” to these unhelpful thoughts through cognitive behavioral therapy, their mental health and quality of life s

Cancer patients benefit from therapy that changes negative thoughts, behavior

Many cancer patients struggle with their conditions by having negative thoughts, behaviors and emotions.However, when they identify and “talk back” to these unhelpful thoughts through cognitive behavioral therapy, their mental health and quality of life s
Liver cancer 'signature' in gut holds clues to cancer risk

Liver cancer 'signature' in gut holds clues to cancer risk

by Caroline Tang,University of New South WalesCredit: Thirdman from PexelsPeople with non-alcohol-related liver cancer have a unique gut microbiome profile which could help predict disease risk,

Liver cancer 'signature' in gut holds clues to cancer risk

by Caroline Tang,University of New South WalesCredit: Thirdman from PexelsPeople with non-alcohol-related liver cancer have a unique gut microbiome profile which could help predict disease risk,
U.S. cancer deaths decline overall, but prostate cancers make rebound

U.S. cancer deaths decline overall, but prostate cancers make rebound

by Dennis ThompsonCancer deaths continue to decline, dropping 33% since 1991 and saving an estimated 3.8 million lives, according to the American Cancer Society's annual statistics report.But indi

U.S. cancer deaths decline overall, but prostate cancers make rebound

by Dennis ThompsonCancer deaths continue to decline, dropping 33% since 1991 and saving an estimated 3.8 million lives, according to the American Cancer Society's annual statistics report.But indi
Researchers: Favorable survival, fewer side effects after reduced therapy for HPV-linked head and neck cancer

Researchers: Favorable survival, fewer side effects after reduced therapy for HPV-linked head and neck cancer

by University of North Carolina at Chapel Hill School of MedicineBhisham Chera, MD. Credit: University of North Carolina at Chapel Hill School of MedicineUniversity of North Carolina Lineberger C

Researchers: Favorable survival, fewer side effects after reduced therapy for HPV-linked head and neck cancer

by University of North Carolina at Chapel Hill School of MedicineBhisham Chera, MD. Credit: University of North Carolina at Chapel Hill School of MedicineUniversity of North Carolina Lineberger C
Evaluation of ruxolitinib, a JAK inhibitor, in multiple myeloma

Evaluation of ruxolitinib, a JAK inhibitor, in multiple myeloma

by Impact Journals LLCRuxolitinib exerts its anti-myeloma effects through several mechanisms. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28547A new research perspective titled &quot

Evaluation of ruxolitinib, a JAK inhibitor, in multiple myeloma

by Impact Journals LLCRuxolitinib exerts its anti-myeloma effects through several mechanisms. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28547A new research perspective titled &quot
Black men found to have greater microvascular dysfunction than white men after prostate cancer diagnosis

Black men found to have greater microvascular dysfunction than white men after prostate cancer diagnosis

byAmerican Physiological SocietyCredit: Pixabay/CC0 Public DomainMicrovascular function is lower is Black men following a recent diagnosis of prostate cancer, compared to white men, according to

Black men found to have greater microvascular dysfunction than white men after prostate cancer diagnosis

byAmerican Physiological SocietyCredit: Pixabay/CC0 Public DomainMicrovascular function is lower is Black men following a recent diagnosis of prostate cancer, compared to white men, according to
How sound waves trigger immune responses to cancer in mice

How sound waves trigger immune responses to cancer in mice

byUniversity of MichiganHistotripsy ablation is followed by infiltration of innate and adaptive immune cell populations. Mice bearing bilateral B16F10 tumors were treated with unilateral sham (c

How sound waves trigger immune responses to cancer in mice

byUniversity of MichiganHistotripsy ablation is followed by infiltration of innate and adaptive immune cell populations. Mice bearing bilateral B16F10 tumors were treated with unilateral sham (c
Study reveals gene 'switched off' in early stages of pancreatic cancer allows rapid tumor growth and spread

Study reveals gene 'switched off' in early stages of pancreatic cancer allows rapid tumor growth and spread

byNottingham Trent UniversityHNF4A is methylated and suppressed in pancreatic cancer. Credit:Gastro Hep Advances(2024). DOI: 10.1016/j.gastha.2024.04.005Scientists at Nottingham Tren

Study reveals gene 'switched off' in early stages of pancreatic cancer allows rapid tumor growth and spread

byNottingham Trent UniversityHNF4A is methylated and suppressed in pancreatic cancer. Credit:Gastro Hep Advances(2024). DOI: 10.1016/j.gastha.2024.04.005Scientists at Nottingham Tren
Antibody-based therapy eliminates circulating tumor cells in mouse models of breast and pancreatic cancer

Antibody-based therapy eliminates circulating tumor cells in mouse models of breast and pancreatic cancer

by Katie Marquedant,Massachusetts General Hospital(A) Schema for the mouse models of neoadjuvant placebo or 23C6 treatment. (B) Tumor volume measurements of 4T1 orthotopic mammary gland tumors i

Antibody-based therapy eliminates circulating tumor cells in mouse models of breast and pancreatic cancer

by Katie Marquedant,Massachusetts General Hospital(A) Schema for the mouse models of neoadjuvant placebo or 23C6 treatment. (B) Tumor volume measurements of 4T1 orthotopic mammary gland tumors i
Updates: MET targeted therapy for EXON 14 mutations in lung cancer

Updates: MET targeted therapy for EXON 14 mutations in lung cancer

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainAnew editorial papertitled "Latest updates on MET targeted therapy for EXON 14 mutations in lung cancer" has been published

Updates: MET targeted therapy for EXON 14 mutations in lung cancer

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainAnew editorial papertitled "Latest updates on MET targeted therapy for EXON 14 mutations in lung cancer" has been published
Researchers discover the role of RNF114B, a key gene in the progression and treatment of lung adenocarcinoma

Researchers discover the role of RNF114B, a key gene in the progression and treatment of lung adenocarcinoma

byUniversitat Pompeu Fabra - BarcelonaA mouse fibroblast with altered RNF144B expression divides without correctly grouping chromosomes (stained blue), resulting in aberrant cells. Credit: UPFRe

Researchers discover the role of RNF114B, a key gene in the progression and treatment of lung adenocarcinoma

byUniversitat Pompeu Fabra - BarcelonaA mouse fibroblast with altered RNF144B expression divides without correctly grouping chromosomes (stained blue), resulting in aberrant cells. Credit: UPFRe